In the course of a viral infection, there is normally a very strong activation of the immune system. But in virtually all of the Long COVID patients studied, corresponding markers such as cytokines, acute phase proteins and eicosan...
The severe acute respiratory syndrome coronavirus (SARS‑CoV)‑2 pandemic has presented unprecedented challenges globally.[1] The viral infection presents with a constellation of symptoms varying from a mild flu‑like illness t...
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is the cause of coronavirus disease 2019 (COVID-19); a severe respiratory distress that has emerged from the city of Wuhan, Hubei province, China during December 2019. COVID-19 is currently the major global health prob...
ACE2 receptors have higher expression in the lungs, heart, oesophagus, kidneys, bladder and ileum and thus these organs are considered more vulnerable to SARS-CoV2 infection [6]. 1.3.4. Host immune responses The host immune response to SARS-CoV-2 is still not fully understood. Viral antigen...
The old argument about the discomfort of using PPE in our humid and hot tropical climate cannot compare to the discomfort of the pain, suffering and associated costs of battling a viral infection as deadly as COVID-19. There is no comparison! While it is still very early in what may be ...
There is an incubation period, and it can take anywhere from a few days to two weeks for people to start to feel an infection.具体是什么样的症状也同样会因人而异。Also, what "feeling it" looks like varies.可能会表现出一些轻微症状，如味觉或嗅觉滞缓，一直到危及生命的呼吸困难或心脏问题这样的...
Part of the COVID-19 illness is viral lung infection (viral pneumonia). A small number of viral pneumonias can also develop a bacterial infection within the lung. The addition of the bacterial infection on top of the viral infection is called a secondary bacterial infection. ...
The blue curve is the estimated cumulative vaccination coverage in the population (right y-axis) when herd immunity is achieved in a and the estimated cumulative infection rate (right y-axis) in (b). Full size image Herd immunity To predict how the pandemic will develop with vaccines, and ...
[34]MANOLISA S, MANOLIST A, MANOLISA A, et al. COVID-19 infection: viral macro-and micro-vascular coagulopathy and thromboembolism/prophylactic and therapeutic management[J]. J Cardiovasc Pharmacol Ther, 2021, 26(1): 12-24. ...
73. World Health Organization. Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected; World Health Organization: Geneva, Switzerland, 2020. 74. Barut, F.; Ozacmak, V.H.; Turan, I.; Sayan...